Home Therapeutic relationship The impact of angiopoietin-2 genetic polymorphisms on susceptibility to breast malignancies

The impact of angiopoietin-2 genetic polymorphisms on susceptibility to breast malignancies

0
  • Sung, H. et al. World Cancer Statistics 2020: GLOBOCAN estimates of worldwide incidence and mortality for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209–249 (2021).

    Google Scholar article

  • Qiu, H., Cao, S. & Xu, R. Cancer incidence, mortality and burden in China: a temporal trend analysis and comparison with the United States and the United Kingdom based on published global epidemiological data in 2020. Common Cancer. (London.) 41(10), 1037-1048 (2021).

    Google Scholar article

  • Cao, M., Li, H., Sun, D. & Chen, W. Cancer burden of major cancers in China: A need for sustainable actions. Common Cancer. (London.) 40(5), 205–210 (2020).

    Google Scholar article

  • Zeng, H. et al. Change in cancer survival in China between 2003 and 2015: a pooled analysis of 17 population-based cancer registries. Lancet Glob. Health 6(5), e555–e567 (2018).

    Google Scholar article

  • Practice Bulletin Number 179. Breast cancer risk assessment and screening in women at average risk. Obstet. Gynecol. 130(1), e1–e16 (2017).

    Google Scholar article

  • Lilyquist, J., Ruddy, KJ, Vachon, CM & Couch, FJ Common genetic variation and past, present, and future breast cancer risk. Cancer epidemiology. Biomark. Prev. 27(4), 380–394 (2018).

    CAS Google Scholar Article

  • Fanale, D. et al. Genome-wide association studies of breast cancer: There is strength in numbers. Oncogene 31(17), 2121-2128 (2012).

    CAS Google Scholar Article

  • Carmeliet, P. & Jain, RK Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347), 298–307 (2011).

    ADS CAS Article Google Scholar

  • Saharinen, P., Eklund, L. & Alitalo, K. Therapeutic targeting of the angiopoietin-TIE pathway. Nat. Rev. Drug Discov. 16(9), 635–661 (2017).

    CAS Google Scholar Article

  • Konac, E. et al. Absence of association between −460 C/T and 936 C/T of vascular endothelial growth factor and polymorphisms of angiopoietin-2 exon 4 G/A and cancers of the ovary, cervix uterus and endometrium. Cell DNA Biol. 26(7), 453–463 (2007).

    CAS Google Scholar Article

  • Bhatraju, Pennsylvania et al. Genetic variation implicates plasma angiopoietin-2 in the development of acute kidney injury subphenotypes. BMC Nephrol. 21(1), 284 (2020).

    CAS Google Scholar Article

  • Dai, C. et al. Correlation between the genetic polymorphism of the angiopoietin-2 gene and the clinical aspects of rheumatoid arthritis. Int. J.Med. Science. 16(2), 331–336 (2019).

    CAS Google Scholar Article

  • Hou, W. et al. Correlations between angiopoietin-2 gene polymorphisms and lung cancer progression in a Chinese Han population. J.Cancer ten(13), 2935-2941 (2019).

    Google Scholar article

  • World Medical, A. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA 310(20), 2191-2194 (2013).

    Google Scholar article

  • Elston, CW & Ellis, IO Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5), 403–10 (1991).

    CAS Google Scholar Article

  • Elston, CW & Ellis, IO Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 41(3A), 154–61 (2002).

    CAS Google Scholar Article

  • Wang, QC et al. Impacts of RETN genetic polymorphism on the development of breast cancer. J.Cancer 11(10), 2769–2777 (2020).

    CAS Google Scholar Article

  • Wang, QC et al. Fascin-1 as a new diagnostic marker for triple-negative breast cancer. CancerMed. 5(8), 1983-1988 (2016).

    CAS Google Scholar Article

  • Wang, QC et al. FSCN1 gene polymorphisms: biomarkers of breast cancer development and progression. Science. representing seven(1), 15887 (2017).

    Article on Google Scholar Ads

  • Du, Z. et al. Angiopoietin-2 gene polymorphisms are biomarkers of colorectal cancer development and progression in Han Chinese. Int. J.Med. Science. 17(1), 97–102 (2020).

    CAS Google Scholar Article

  • Zhang, L., Zhang, Y., Tang, CH & Su, CM RAD52 gene polymorphisms are associated with colorectal cancer risk in a Chinese Han population. Medicine (Baltimore) 96(49), e8994 (2017).

    CAS Google Scholar Article

  • Yang, YC et al. Melatonin reduces lung cancer strain by inhibiting PLC, ERK, p38, beta-catenin and Twist pathways. About. Toxicol. 34(2), 203–209 (2019).

    ADS CAS Article Google Scholar

  • Chen, Y.A. et al. Simvastatin sensitizes radioresistant prostate cancer cells by impairing the repair of DNA double-strand breaks. Front. Pharmacol. 9600 (2018).

    Google Scholar article

  • King, MC, Marks, JH, Mandell, JB, New York Breast Cancer Study, G. Risks of breast and ovarian cancer due to inherited BRCA1 and BRCA2 mutations. Science 302(5645), 643–6 (2003).

    ADS CAS Article Google Scholar

  • Stratton, MR & Rahman, N. The emerging landscape of breast cancer susceptibility. Nat. Broom. 40(1), 17-22 (2008).

    CAS Google Scholar Article

  • Fanfani, V., Zatopkova, M., Harris, AL, Pezzella, F. & Stracquadanio, G. Dissection of hereditary breast cancer risk: from statistical methods to susceptibility genes. Semin. Cancer Biol. 72175–184 (2021).

    CAS Google Scholar Article

  • Yu, K., Lee, CH, Tan, PH, and Tan, P. Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression in distinct ethnic populations. Clin. Cancer Res. ten(16), 5508–5517 (2004).

    CAS Google Scholar Article

  • Fan, L. et al. Breast cancer in China. Lancet Oncol. 15(7), e279–e289 (2014).

    Google Scholar article

  • Makhoul, I. et al. Germline genetic variants of TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA are associated with pathological complete response to bevacizumab in breast cancer patients. PLoS One 12(1), e0168550 (2017).

    Google Scholar article

  • Robinson, M. et al. Olaparib for metastatic breast cancer in patients with germline BRCA mutation. N.Engl. J.Med. 377(6), 523-533 (2017).

    CAS Google Scholar Article

  • Chai, Y. et al. Homologous recombination deficiency (HRD) and BRCA 1/2 gene mutation to predict the effect of neoadjuvant platinum-based chemotherapy in early-stage triple-negative breast cancer (TNBC): a systematic review and meta-analysis . J.Pers. Med. 12(2), 323 (2022).

    Google Scholar article

  • Blanco-Gomez, A. et al. Stromal SNAI2 Is required for breast cancer progression ERBB2. Cancer Res. 80(23), 5216–5230 (2020).

    CAS Google Scholar Article

  • Devlin, B. & Risch, N. A comparison of linkage disequilibrium metrics for fine-scale mapping. Genomics 29(2), 311–322 (1995).

    CAS Google Scholar Article

  • Shifman, S. et al. A highly significant association between a COMT haplotype and schizophrenia. A m. J. Hum. Broom. 71(6), 1296–1302 (2002).

    CAS Google Scholar Article